Larvol Delta - Evaluation-of-the-Safety-Tolerability-and-Efficacy-of-MDGN002-in-Adults-With-Moderate-to-Severe-Active-Crohn39s-Disease

CERC-002 - Kyowa Kirin, Sanofi, Cerecor

http://clinicaltrials.gov/ct2/show/NCT03169894

Jul 6, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next